Skip to content
Cryptos: 603Market Cap: $3.44T 1.8%24h Vol: $149.01BDominance: BTC 46.9% ETH 8.6%
Open Tradzy

New high · Argentina stocks

Johnson & Johnson (JNJ) closes at a 52-week high of ARS 30,780.00

Its second new 52-week high in 5 sessions. Up 12.5% over 20 sessions.

Published 4 November 2026 · Written from Tradzy's price and volume data

Close
ARS 30,780.00
On the day
+4.1%
Volume
0.6× average
vs 52-week high
New high

Johnson & Johnson closing prices

ARS 26,000.00ARS 28,000.00ARS 30,000.00Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26ARS 30,780.00

The last 90 closes up to 4 November 2026. The live chart is on the JNJ page.

What happened

Johnson & Johnson (JNJ) closed at ARS 30,780.00 on 4 November 2026, up 4.1% from ARS 29,560.00 the session before.

It is the second new high in the last 5 sessions. Over 5 sessions the price is up 2.7%, and over 20 sessions it is up 12.5%.

That close is above every close of the past year. The previous highest was ARS 30,320.00 on 29 Oct 2026, and the new close is 1.5% above it.

Trading was light: volume was 62% of its recent average.

Across the 13 BUENOSAIRES stocks we track, 9 closed higher and 4 closed lower that day, with a median change of +3.30%. JNJ's change was +4.1%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeARS 29,560.00
CloseARS 30,780.00
Change on the day+4.13%
Change over 5 sessions+2.74%
Change over 20 sessions+12.50%
Volume9,941
Average volume, up to 20 sessions before15,921
Volume against that average0.6 times
Highest close in the past yearARS 30,320.00 (29 Oct 2026)
Lowest close in the past yearARS 18,310.00 (7 Nov 2025)

The full chart and history are on Johnson & Johnson (JNJ). More from this market: BUENOSAIRES news today.

More BUENOSAIRES moves on 4 November 2026

Want a plan for JNJ? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.